eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Is there still a place for neutrophil gelatinase-associated lipocalin to serve as a biomarker in psoriasis?

Aleksandra Frątczak 
1
,
Agnieszka Łupicka-Słowik
2
,
Marcin Sieńczyk
2
,
Karina Polak
1
,
Beata Bergler-Czop
1
,
Bartosz Miziołek
1

  1. Department of Dermatology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
  2. Department of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw, Poland
Adv Dermatol Allergol
DOI: https://doi.org/10.5114/ada.2024.142572
Online publish date: 2024/08/29
Article files
- Is there - Fratczak.pdf  [0.38 MB]
- Is there - Supplementary.pdf  [0.04 MB]
Get citation
 
 
1. Aronson JK, Ferner RE. Biomarkers-a general review. Curr Protoc Pharmacol 2017; 76: 9.23.1-9.23.17.
2. Navrazhina K, Garcet S, Gonzalez J, et al. In-depth analysis of the hidradenitis suppurativa serum proteome identifies distinct inflammatory subtypes. J Invest Dermatol 2021; 141: 2197-207.
3. Wolk K, Wenzel J, Tsaousi A, et al. Lipocalin-2 is expressed by activated granulocytes and keratinocytes in affected skin and reflects disease activity in acne inversa/hidradenitis suppurativa. Br J Dermatol 2017; 177: 1385-93.
4. Möller H, Ohlsson K, Linder C, et al. The flare-up reactions after systemic provocation in contact allergy to nickel and gold. Contact Dermatitis 1999; 40: 200-4.
5. Serra R, Buffone G, Falcone D, et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013; 21: 395-401.
6. Shao S, Cao T, Jin L, et al. Increased lipocalin-2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion. Invest Dermatol 2016; 136: 1418-28.
7. Seo SJ, Ahn JY, Hong CK, et al. Expression of neutrophil gelatinase-associated lipocalin in skin epidermis. J Invest Dermatol 2006; 126: 510-2.
8. Hau CS, Kanda N, Tada Y, et al. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response. J Dermatol 2016; 43: 785-94.
9. Ren K, Xia Y. Lipocalin 2 participates in the epidermal differentiation and inflammatory processes of psoriasis. J Inflamm Res 2022; 15: 2157-66.
10. Visvanathan S, Baum P, Vinisko R, et al. Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. J Allergy Clin Immunol 2019; 143: 2158-69.
11. Hay RA, Samir N, Safwat M, et al. Tissue lipocalin-2 in psoriasis: is it a marker of metabolic disturbance or a possible marker of therapeutic efficacy after narrow band ultraviolet B? J Dermatolog Treat 2020; 31: 519-23.
12. Frątczak A, Miziołek B, Łupicka-Słowik A, et al. Significance of neutrophil gelatinase-associated lipocalin (NGAL) and proprotein convertase subtilisin/kexin type 9 (PCSK9) for the monitoring of treatment response to cyclosporine in patients with psoriasis. Life (Basel) 2023; 13: 1873.
13. Wolk K, Frambach Y, Jacobi A, et al. Increased levels of lipocalin 2 in palmoplantar pustular psoriasis. J Dermatol Sci 2018; 90: 68-74.
14. Gul FC, Cicek D, Kaman D, et al. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behçet’s disease. Eur J Dermatol 2015; 25: 195-7.
15. Romaní J, Caixàs A, Ceperuelo-Mallafré V, et al. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI. Arch Dermatol Res 2013; 305: 105-12.
16. Kamata M, Tada Y, Tatsuta A, et al. Serum lipocalin-2 levels are increased in patients with psoriasis. Clin Exp Dermatol 2012; 37: 296-9.
17. Ataseven A, Kesli R, Kurtipek GS, Ozturk P. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, inter-leukin-6, homocysteine, and uric acid levels in patients with psoriasis. Dis Markers 2014; 2014: 541709.
18. Aizawa N, Ishiuji Y, Tominaga M, et al. Relationship between the degrees of itch and serum lipocalin-2 levels in patients with psoriasis. J Immunol Res 2019; 2019: 8171373.
19. Baran A, Świderska M, Myśliwiec H, Flisiak I. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels. J Dermatolog Treat 2017; 28: 136-40.
20. Colak S, Omma A, Sandikci SC, et al. Vaspin, neutrophil gelatinase-associated lipocalin and apolipoprotein levels in patients with psoriatic arthritis. Bratisl Lek Listy 2019; 120: 65-9.
21. Sokolova MV, Simon D, Nas K, et al. A set of serum markers detecting systemic inflammation in psoriatic skin, entheseal, and joint disease in the absence of C-reactive protein and its link to clinical disease manifestations. Arthritis Res Ther 2020; 22: 26.
22. El-Hadidi H, Samir N, Shaker OG, Otb S. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome. Arch Dermatol Res 2014; 306: 239-45.
23. Mallbris L, O’Brien KP, Hulthén A, et al. Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 2002; 11: 584-91.
24. Lee JH, Kye KC, Seo EY, et al. Expression of neutrophil gelatinase-associated lipocalin in calcium-induced keratinocyte differentiation. J Korean Med Sci 2008; 23: 302-6.
25. Hau CS, Kanda N, Tada Y, et al. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response. J Dermatol 2016; 43: 785-94.
26. Stisen ZR, Nielsen SM, Ditlev SB, et al. Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study. Scand J Rheumatol 2024; 53: 21-8.
27. Dopytalska K, Sobolewski P, Błaszczak A, et al. Psoriasis in special localizations. Reumatologia 2018; 56: 392-8.
28. Furutani K, Chen O, McGinnis A, et al. Novel proresolving lipid mediator mimetic 3-oxa-PD1n-3 docosapentaenoic acid reduces acute and chronic itch by modulating excitatory and inhibitory synaptic transmission and astroglial secretion of lipocalin-2 in mice. Pain 2023; 164: 1340-54.
29. Bazid HAS, Sakr HG, Abdallah RA, et al. Serum and tissue lipocalin-2 expression in chronic kidney disease pruritic patients. Appl Immunohistochem Mol Morphol 2023; 31: 635-43.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.